U.S. market Closed. Opens in 11 hours 55 minutes

ELEV | Elevation Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue39.00K27.00K18.00K15.00KN/A
Gross Profit-39.00K-27.00K-18.00K-15.00KN/A
Operating Expenses40.30M94.55M32.05M17.28M5.88M
Selling, General & Admin14.87M15.83M8.45M1.80M544.00K
Research & Development25.43M78.72M23.59M15.48M5.34M
Other Operating Expenses5.11M-506.00K7.00K11.00KN/A
Operating Income-40.34M-94.55M-32.05M-17.28M-5.88M
Other Expenses / Income-5.34M-506.00K7.00K11.00K-5.25M
Before Tax Income-45.67M-95.06M-32.04M-17.27M-5.88M
Income Tax Expenses30.00K25.00K-218.56K-191.30K-8.82K
Net Income-45.70M-95.08M-32.04M-17.27M-5.88M
Interest Expenses4.17M479.00KN/AN/AN/A
Basic Shares Outstanding34.08M23.27M23.21M23.76M23.76M
Diluted Shares Outstanding34.08M23.27M23.21M23.76M23.76M
EBITDA-40.30M-94.55M-32.03M-17.26M-5.88M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-41.51M-94.58M-32.26M-17.46M-5.89M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙